Small molecule targeting NaV1.7 via inhibition of the CRMP2-Ubc9 interaction reduces and prevents pain chronification in a mouse model of oxaliplatin-induced neuropathic pain-Reference-Cited by-同舟云学术

Small molecule targeting NaV1.7 via inhibition of the CRMP2-Ubc9 interaction reduces and prevents pain chronification in a mouse model of oxaliplatin-induced neuropathic pain

Published:2022-01 Issue: Volume:11 Page:100082
ISSN:2452-073X
Container-title:Neurobiology of Pain
language:en
Short-container-title:Neurobiology of Pain

Author:

Braden Kathryn,Stratton Harrison J.,Salvemini Daniela,Khanna Rajesh

Funder

National Institute of Neurological Disorders and Stroke

Saint Louis University

National Institutes of Health

National Institute on Drug Abuse

Publisher

Elsevier BV

Subject

Anesthesiology and Pain Medicine,Neurology (clinical),Neuroscience (miscellaneous)

Reference53 articles.

1. Akin, E.J., Alsaloum, M., Higerd, G.P., Liu, S., Zhao, P., Dib-Hajj, F.B., Waxman, S.G., Dib-Hajj, S.D., 2021. Paclitaxel increases axonal localization and vesicular trafficking of Nav1.7. Brain.

2. Subtype-Selective Small Molecule Inhibitors Reveal a Fundamental Role for Nav1.7 in Nociceptor Electrogenesis, Axonal Conduction and Presynaptic Release;Alexandrou;PloS one,2016

3. Benson, M., Iñiguez-Lluhí, J.A., Martens, J. 2009. SUMO Modification of Ion Channels. In: SUMO Regulation of Cellular Processes. pp. 117-136. Ed. V.G. Wilson. Springer Netherlands: Dordrecht.

4. Benson, M.D., Li, Q.-J., Kieckhafer, K., Dudek, D., Whorton, M.R., Sunahara, R.K., Iñiguez-Lluhí, J.A., Martens, J.R., 2007. SUMO Modification Regulates Inactivation of the Voltage-Gated Potassium Channel Kv1.5. Proceedings of the National Academy of Sciences - PNAS 104, 1805-1810.

5. Berge, O.-G., 2011. Predictive validity of behavioural animal models for chronic pain. British journal of pharmacology 164, 1195-1206.

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SUMOylation and DeSUMOylation: Tug of War of Pain Signaling;Molecular Neurobiology;2024-09-14

2. Small molecule targeting NaV1.7 via inhibition of CRMP2-Ubc9 interaction reduces pain-related outcomes in a rodent osteoarthritic model;Pain;2024-07-26

3. Ion Channel and Transporter Involvement in Chemotherapy-Induced Peripheral Neurotoxicity;International Journal of Molecular Sciences;2024-06-14

4. Peptide and Peptidomimetic Inhibitors Targeting the Interaction of Collapsin Response Mediator Protein 2 with the N-Type Calcium Channel for Pain Relief;ACS Pharmacology & Translational Science;2024-06-06

5. Thermal escape box: A cost-benefit evaluation paradigm for investigating thermosensation and thermal pain;Neurobiology of Pain;2024-01